文献
J-GLOBAL ID:202202276219091611
整理番号:22A0827879
中等度から重度のプラーク乾癬(IXORA-PEDS)の小児患者におけるイキセキズマブの母集団薬物動態と曝露有効性分析【JST・京大機械翻訳】
Population pharmacokinetic and exposure-efficacy analysis of ixekizumab in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS)
著者 (10件):
Jackson Kimberley
(Eli Lilly and Company, Bracknell, UK)
,
Chua Laiyi
(Lilly Centre for Clinical Pharmacology, Singapore, Singapore)
,
Velez de Mendizabal Nieves
(Metrum Research Group, LLC, Tariffville, CT, USA)
,
Pitou Celine
(Eli Lilly and Company, Bracknell, UK)
,
Rodriguez Capriles Claudia
(Eli Lilly and Company, Indianapolis, IN, USA)
,
Paller Amy S.
(Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA)
,
Lansang Perla
(Sunnybrook Health Sciences Centre, Toronto, ON, Canada)
,
Seyger Marieke M. B.
(Department of Dermatology, Radboud University Medical Centre, Nijmegen, The Netherlands)
,
Papp Kim
(K Papp Clinical Research and Probity Medical Research, Waterloo, ON, Canada)
,
IXORA-PEDS study group
資料名:
British Journal of Clinical Pharmacology
(British Journal of Clinical Pharmacology)
巻:
88
号:
3
ページ:
1074-1086
発行年:
2022年
JST資料番号:
C0957B
ISSN:
0306-5251
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)